📖
Immunomodulatory RIG-I Agonist SLR14 Confers Protection Against a Range of Highly Pathogenic Negative Sense RNA viruses.
Meier K, Olejnik J, Velasquez-Reyes JM, Westover JB, Bawa P, Wrobel ER, Henderson CW, Hu P, Hume AJ, Holtz AM, Fedorova O, Mostoslavsky G, Kotton DN, Connor JH, Marzi A, Gowen BB, Pyle AM, Mühlberger E

Immunomodulatory RIG-I Agonist SLR14 Confers Protection Against a Range of Highly Pathogenic Negative Sense RNA viruses.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in bioRxiv.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Immunomodulatory RIG-I Agonist SLR14 Confers Protection Against a Range of Highly Pathogenic Negative Sense RNA viruses.
Author / Organization Meier K, Olejnik J, Velasquez-Reyes JM, Westover JB, Bawa P, Wrobel ER, Henderson CW, Hu P, Hume AJ, Holtz AM, Fedorova O, Mostoslavsky G, Kotton DN, Connor JH, Marzi A, Gowen BB, Pyle AM, Mühlberger E
Subject & Discipline bioRxiv
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-18361
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »